Letpro 2.5 mg Tablet 5 is used to treat early breast cancer. It is a single-ingredient aromatase inhibitor medicine containing letrozole.
This medicine treats hormone-receptor-positive early breast cancer in women post-menopause. It also provides extended treatment following initial tamoxifen therapy. It also treats locally advanced or metastatic hormone-sensitive breast cancer.
Before starting, tell your doctor about your medical conditions and allergies. Tell the doctor about all other medicines, supplements or herbal products you take. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. Attend any monitoring appointments advised by your doctor. Report persistent or serious side effects to your doctor. Do not stop taking or using the medicine unless your doctor advises you to do so.


















































